Cantor Fitzgerald Initiates Coverage On MiMedx Group With Overweight Rating, Announces Price Target of $11
Cantor Fitzgerald Initiates Coverage On MiMedx Group With Overweight Rating, Announces Price Target of $11
康德爾菲茨傑（Cantor Fitzgerald）開始對mimedx集團進行覆蓋，並宣佈目標價格爲11美元。
Cantor Fitzgerald analyst Ross Osborn initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Overweight rating and announces Price Target of $11.
康特菲茨傑分析師Ross Osborn 以超配評級覆蓋MiMedx Group (納斯達克: mimedx)，宣佈目標價爲11美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。